FDA Deals Sequenom Blow, Says SEQureDx Appears to Be an IVD

The agency sent the company a letter Monday saying the test, which it claims the company is "currently marketing," "appears to meet the definition of a device," which means Sequenom will need to seek FDA approval or convince the agency otherwise. Trouble is, Sequenom says the test is still in development.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.